top of page
Incubate Comment In Response To The FTC’s Request For Comments On The Business Practices Of PBMs
Read Incubate's response to the FTC's Solicitation for Public Comments on the Business Practices of Pharmacy Benefit Managers and Their...
Incubate Coalition
May 24, 2022
Incubate Executive Director John Stanford Statement In Response To The Centers For Medicare & Medicaid Services’ Devastating Final National Coverage Determination For Certain Alzheimer’s Treatments
See Executive Director John Stanford's statement on CMS' Final NCD on Alzheimer's disease and how this will affect the future of...
Incubate Coalition
Apr 13, 2022
To Spend Less On Healthcare, Invest In More Medicines
Read John Stanford and JF Formela's op-ed on how we can lower health costs by spending more on drugs. By JF Formela and John Stanford The...
Incubate Coalition
Apr 4, 2022
Moonshot Statement
Read Incubate Executive Director John Stanford's statement on President BIden's Moonshot initiative. Incubate Executive Director John...
Incubate Coalition
Feb 2, 2022
The Impact Of Price Controls On Investment Into Small Biotech Innovation
This report attempts to understand the implications of price controls on the early-stage life science industry. In the U.S., policymakers...
Incubate Coalition
Nov 11, 2021
Leading Venture Capital Group Concerned With Prescription Drug Deal
"As investors in biotechnology and pharmaceuticals, we're highly concerned about the potential consequences of the new drug-pricing...
Incubate Coalition
Nov 3, 2021
bottom of page